What Dermatologists Want Psoriasis Patients on GLP-1s to Know
My AccountFIND A DOCTORNewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSkin ConditionsSmileSun CareTreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareAnti-WrinkleRegenerative AestheticsBodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessFitnessGLP-1sHealthMenopauseBEAUTYPASSNewsView All NewsCelebrityNew LaunchesTreatment & FDA NewsIndustry & Retail NewsFaceView All FaceAcneAnti-AgingCelebrityEye CareHyperpigmentationMakeupSensitive SkinSkin CareSkin ConditionsSmileSun CareTreatmentsView All TreatmentsNeurotoxinsFillersLasers & Energy DevicesMicroneedlingPost-Procedure Skin CareAnti-WrinkleRegenerative AestheticsBodyView All BodySkin CareBody SculptingBreastsButtsCelluliteFragranceHands + NailsLegsPregnancyHairView All HairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsView All AwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingView All ShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessView All WellnessFitnessGLP-1sHealthMenopauseLoading…FIND A DOCTORBEAUTYPASS Advertisement Home›Skin Care›Chronic Skin Conditions What Dermatologists Want Psoriasis Patients on GLP-1s to Know The possible perk has nothing to do with the number on the scale. GLP-1 medications have already changed how many people think about weight and metabolic health. Now dermatologists are exploring another potential benefit: whether the drugs could also improve psoriasis, as reported by Dermatology Times. A new primer from the National Psoriasis Foundation’s Medical Board, published in JAMA Dermatology, doesn’t present new clinical trial data. Instead, it synthesizes the emerging research on GLP-1 receptor agonists—the drug class that includes Ozempic and Wegovy—and offers practical guidance for dermatologists. The timing matters: many people with psoriasis are already taking these medications for obesity or type 2 diabetes, two conditions that commonly overlap with the inflammatory skin disease.